Cadrenal Therapeutics (CVKD) Other Working Capital Changes (2022 - 2025)

Cadrenal Therapeutics (CVKD) posted Other Working Capital Changes of -$1.0 for Q4 2025, down 200.0% sequentially from $1.0 in Q4 2023.

Cadrenal Therapeutics (CVKD) Other Working Capital Changes (2022 - 2025) Analysis & Trends

Cadrenal Therapeutics has reported Other Working Capital Changes for 3 years, with the latest figure at -$1.0 in Q4 2025.

Quarterly Other Working Capital Changes changed N/A year-over-year to -$1.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.0 (changed N/A YoY) and the FY2025 annual result came in at -$1625.0, changed N/A from the prior year.
Other Working Capital Changes slipped to -$1.0 in Q4 2025 per CVKD's latest filing, from $1.0 in the prior quarter.
Over five years, Other Working Capital Changes peaked at $3792.0 in Q4 2022 and troughed at -$2196.0 in Q1 2023.
A 3-year average of $473.88 and a median of $1.0 in 2023 frame the typical range for Other Working Capital Changes.
The widest YoY moves for Other Working Capital Changes: up 99.91% in 2023, down 300.18% in 2023.
Over 3 years, Other Working Capital Changes stood at $3792.0 in 2022, then tumbled by 99.97% to $1.0 in 2023, then slumped by 200.0% to -$1.0 in 2025.
According to Business Quant data, Other Working Capital Changes over the past three periods registered -$1.0, $1.0, and -$1.0 for Q4 2025, Q4 2023, and Q3 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Cadrenal Therapeutics	4.59 Mn	2.19 Mn	-

Download Data